Patents by Inventor Richard Tuli

Richard Tuli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911470
    Abstract: Provided herein are methods for treating pancreatic cancer using a combination of radiotherapy and an agent that inhibits binding of PD-L1 to PD1 (e.g., durvalumab).
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: February 27, 2024
    Assignee: Cedars-Sinai Medical Center
    Inventor: Richard Tuli
  • Patent number: 11149300
    Abstract: The present invention provides for the treatment of gastrointestinal malignancies such as pancreatic cancer. The treatment includes a combination of Poly (ADP-ribose) polymerase (PARP) inhibitor, radiation therapy, and chemotherapy. The invention also provides methods of identifying patients with DNA pathway repair gene defects who will benefit from the treatment methods described.
    Type: Grant
    Filed: January 24, 2019
    Date of Patent: October 19, 2021
    Assignee: Cedars-Sinai Medical Center
    Inventor: Richard Tuli
  • Publication number: 20200114004
    Abstract: Provided herein are methods for treating pancreatic cancer using a combination of radiotherapy and an agent that inhibits binding of PD-L1 to PD1 (e.g., durvalumab).
    Type: Application
    Filed: August 2, 2019
    Publication date: April 16, 2020
    Applicant: Cedars-Sinai Medical Center
    Inventor: Richard Tuli